Multimorbidity and SARS-CoV-2 infection in UK Biobank
- 1 September 2020
- journal article
- editorial
- Published by Elsevier BV in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 14 (5), 775-776
- https://doi.org/10.1016/j.dsx.2020.06.003
Abstract
No abstract availableFunding Information
- National Institute for Health Research
- Applied Research Collaboration East Midlands
This publication has 5 references indexed in Scilit:
- Dynamic linkage of COVID-19 test results between Public Health England’s Second Generation Surveillance System and UK BiobankMicrobial Genomics, 2020
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2020
- Setting performance targets in pay for performance programmes: what can we learn from QOF?BMJ, 2014
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional studyThe Lancet, 2012
- The Measurement of Multiple Chronic Diseases--A Systematic Review on Existing Multimorbidity IndicesThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010